305 related articles for article (PubMed ID: 30930440)
61. Correlating bilayer tablet delamination tendencies to micro-environmental thermodynamic conditions during pan coating.
Zacour BM; Pandey P; Subramanian G; Gao JZ; Nikfar F
Drug Dev Ind Pharm; 2014 Jun; 40(6):829-37. PubMed ID: 23638984
[TBL] [Abstract][Full Text] [Related]
62. Difference in the Dissolution Behaviors of Tablets Containing Polyvinylpolypyrrolidone (PVPP) Depending on Pharmaceutical Formulation After Storage Under High Temperature and Humid Conditions.
Takekuma Y; Ishizaka H; Sumi M; Sato Y; Sugawara M
J Pharm Pharm Sci; 2016; 19(4):511-519. PubMed ID: 28057169
[TBL] [Abstract][Full Text] [Related]
63. QbD-Based Development and Validation of Novel Stability-Indicating Method for the Assay and Dissolution of Garenoxacin in Garenoxacin Tablets.
Azhakesan A; Kuppusamy S
J AOAC Int; 2022 Mar; 105(2):370-378. PubMed ID: 34894249
[TBL] [Abstract][Full Text] [Related]
64. Comparative evaluation of two direct compression lactose grades for pyridoxine hydrochloride tablets.
Aly SA; Udeala OK
Pharmazie; 1988 Mar; 43(3):188-90. PubMed ID: 3380861
[TBL] [Abstract][Full Text] [Related]
65. Correlation of dissolution and disintegration results for an immediate-release tablet.
Nickerson B; Kong A; Gerst P; Kao S
J Pharm Biomed Anal; 2018 Feb; 150():333-340. PubMed ID: 29287259
[TBL] [Abstract][Full Text] [Related]
66. The role of intra- and extragranular microcrystalline cellulose in tablet dissolution.
Li JZ; Rekhi GS; Augsburger LL; Shangraw RF
Pharm Dev Technol; 1996 Dec; 1(4):343-55. PubMed ID: 9552318
[TBL] [Abstract][Full Text] [Related]
67. Simultaneous chemometric determination of pyridoxine hydrochloride and isoniazid in tablets by multivariate regression methods.
Dinç E; Ustündağ O; Baleanu D
Drug Test Anal; 2010 Aug; 2(8):383-7. PubMed ID: 20645279
[TBL] [Abstract][Full Text] [Related]
68. Near infrared spectroscopy to monitor drug release in-situ during dissolution tests.
Sarraguça MC; Matias R; Figueiredo R; Ribeiro PR; Martins AT; Lopes JA
Int J Pharm; 2016 Nov; 513(1-2):1-7. PubMed ID: 27601336
[TBL] [Abstract][Full Text] [Related]
69. Prediction of Dissolution Data Integrated in Tablet Database Using Four-Layered Artificial Neural Networks.
Takayama K; Kawai S; Obata Y; Todo H; Sugibayashi K
Chem Pharm Bull (Tokyo); 2017; 65(10):967-972. PubMed ID: 28966281
[TBL] [Abstract][Full Text] [Related]
70. Influence of pH Modulation on Dynamic Behavior of Gel Layer and Release of Weakly Basic Drug from HPMC/Wax Matrices, Controlled by Acidic Modifiers Evaluated by Multivariate Data Analysis.
Mašková E; Kubová K; Vysloužil J; Pavloková S; Vetchý D
AAPS PharmSciTech; 2017 May; 18(4):1242-1253. PubMed ID: 27474035
[TBL] [Abstract][Full Text] [Related]
71. Initial dissolution kinetics of cocrystal of carbamazepine with nicotinamide.
Hattori Y; Sato M; Otsuka M
J Pharm Pharmacol; 2015 Nov; 67(11):1512-8. PubMed ID: 26285918
[TBL] [Abstract][Full Text] [Related]
72. Enhanced dissolution of sildenafil citrate as dry foam tablets.
Sawatdee S; Atipairin A; Sae Yoon A; Srichana T; Changsan N
Pharm Dev Technol; 2019 Jan; 24(1):1-11. PubMed ID: 28135896
[TBL] [Abstract][Full Text] [Related]
73. Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models.
Uebbing L; Klumpp L; Webster GK; Löbenberg R
Drug Des Devel Ther; 2017; 11():1163-1174. PubMed ID: 28442890
[TBL] [Abstract][Full Text] [Related]
74. Compression of coated drug beads for sustained release tablet of glipizide: formulation, and dissolution.
Nguyen C; Christensen JM; Ayres JW
Pharm Dev Technol; 2014 Feb; 19(1):10-20. PubMed ID: 23259589
[TBL] [Abstract][Full Text] [Related]
75. STUDY OF OFLOXACIN ENANTIOMERS DISSOLUTION FROM SELECTED SOLID DOSAGE FORMS USING HIGH PERFORMANCE CAPILLARY ELECTROPHORESIS METHOD.
Urbaniak B; Milanowski B; Lulek J; Kokot ZJ
Acta Pol Pharm; 2017 May; 74(3):955-968. PubMed ID: 29513966
[TBL] [Abstract][Full Text] [Related]
76. Sustained Release Bilayer Tablet of Ibuprofen and Phenylephrine Hydrochloride: Preparation and Pharmacokinetics in Beagle Dogs.
Zhu C; Xu S; Han X; Wang W; He W; Yin L; Yang L; Qin C
AAPS PharmSciTech; 2019 Jan; 20(2):86. PubMed ID: 30673916
[TBL] [Abstract][Full Text] [Related]
77. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
[TBL] [Abstract][Full Text] [Related]
78. Enabling real time release testing by NIR prediction of dissolution of tablets made by continuous direct compression (CDC).
Pawar P; Wang Y; Keyvan G; Callegari G; Cuitino A; Muzzio F
Int J Pharm; 2016 Oct; 512(1):96-107. PubMed ID: 27543350
[TBL] [Abstract][Full Text] [Related]
79. In-Process Control Assay of Pharmaceutical Microtablets Using Hyperspectral Imaging Coupled with Multivariate Analysis.
Kandpal LM; Tewari J; Gopinathan N; Boulas P; Cho BK
Anal Chem; 2016 Nov; 88(22):11055-11061. PubMed ID: 27731983
[TBL] [Abstract][Full Text] [Related]
80. Probing the early stages of tablet disintegration by stress relaxation measurement.
Tomas J; Schöngut M; Dammer O; Beránek J; Zadražil A; Štěpánek F
Eur J Pharm Sci; 2018 Nov; 124():145-152. PubMed ID: 30149061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
